Today

Agents

Chat

Arena

Discover

More

App

RenovoRx joins JonesTrading webinar on TAMP platform in pancreatic cancer - RNXT News | Rallies

RenovoRx joins JonesTrading webinar on TAMP platform in pancreatic cancer

RNXT•2026-08-04

RenovoRx to join JonesTrading virtual webinar

RenovoRx will join a JonesTrading virtual key opinion leader webinar on Aug. 13, 2026 at 1:30 p.m. ET.

Discussion will center on the TAMP drug-delivery platform, RenovoCath commercialization, and the Phase III TIGeR-PaC pancreatic cancer trial.

CEO Shaun Bagai will participate alongside clinicians from Moffitt Cancer Center and AdventHealth Cancer Institute.

Related News

MKS declares quarterly cash dividend of $0.25 per share

MKSI•2026-08-04

Life Time Group Holdings, Inc. Raises Target Price to $57 From $43

LTH•2026-08-04

Wall St set to open higher on strong AI-linked earnings, Mideast deal hopes

2026-08-04

Adyen partners with LillyDirect to provide payment technology services

LLY•2026-08-04

Waste Management Inc <WM.N>: UBS raises target price to $270 from $265

WM•2026-08-04